Kristine Ball sold $1.9M of Oruka Therapeutics stock
By AlphaYouPublished Form 4
BALL KRISTINE M
Reporting filer
Kristine Ball reported selling 18,000 shares of Oruka Therapeutics, Inc. for about $1.9M ($104.93 a share on average). Form 4 filed Nov 14, 2026 lists 8 entries.
See the price move since this trade →
- Disclosed
- Nov 14, 2026
Reported details
8 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | BALL KRISTINE M | 2026-11-12 | M | Exercise or conversion | 18000 | 6.84 | 18,000 | 2 days | Filed terms
|
| Common Stock | BALL KRISTINE M | 2026-11-12 | S | Sale | 1196 | 102.0967 | 16,804 | 2 days | Filed terms
|
| Common Stock | BALL KRISTINE M | 2026-11-12 | S | Sale | 1300 | 103.0932 | 15,504 | 2 days | Filed terms
|
| Common Stock | BALL KRISTINE M | 2026-11-12 | S | Sale | 2039 | 104.1622 | 13,465 | 2 days | Filed terms
|
| Common Stock | BALL KRISTINE M | 2026-11-12 | S | Sale | 10765 | 105.3141 | 2,700 | 2 days | Filed terms
|
| Common Stock | BALL KRISTINE M | 2026-11-12 | S | Sale | 2500 | 106.0520 | 200 | 2 days | Filed terms
|
| Common Stock | BALL KRISTINE M | 2026-11-12 | S | Sale | 200 | 106.9850 | 0 | 2 days | Filed terms
|
| Stock Option (Right to Buy) (derivative) | BALL KRISTINE M | 2026-11-12 | M | Exercise or conversion | 18000 | 0 | 53,426 | 2 days | Filed terms
|
Common Stock
- Owner
- BALL KRISTINE M
- Date
- 2026-11-12
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 18000
- Price
- 6.84
- Following holdings
- 18,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-12
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 18000
- transaction Price Per Share: 6.84
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 18000
- direct Or Indirect Ownership: D
Common Stock
- Owner
- BALL KRISTINE M
- Date
- 2026-11-12
- Code
- S
- Action
- Sale
- Quantity
- 1196
- Price
- 102.0967
- Following holdings
- 16,804
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-12
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 1196
- transaction Price Per Share: 102.0967
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 16804
- direct Or Indirect Ownership: D
Common Stock
- Owner
- BALL KRISTINE M
- Date
- 2026-11-12
- Code
- S
- Action
- Sale
- Quantity
- 1300
- Price
- 103.0932
- Following holdings
- 15,504
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-12
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 1300
- transaction Price Per Share: 103.0932
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 15504
- direct Or Indirect Ownership: D
Common Stock
- Owner
- BALL KRISTINE M
- Date
- 2026-11-12
- Code
- S
- Action
- Sale
- Quantity
- 2039
- Price
- 104.1622
- Following holdings
- 13,465
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-12
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 2039
- transaction Price Per Share: 104.1622
- id: F4
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 13465
- direct Or Indirect Ownership: D
Common Stock
- Owner
- BALL KRISTINE M
- Date
- 2026-11-12
- Code
- S
- Action
- Sale
- Quantity
- 10765
- Price
- 105.3141
- Following holdings
- 2,700
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-12
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 10765
- transaction Price Per Share: 105.3141
- id: F5
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 2700
- direct Or Indirect Ownership: D
Common Stock
- Owner
- BALL KRISTINE M
- Date
- 2026-11-12
- Code
- S
- Action
- Sale
- Quantity
- 2500
- Price
- 106.0520
- Following holdings
- 200
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-12
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 2500
- transaction Price Per Share: 106.0520
- id: F6
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 200
- direct Or Indirect Ownership: D
Common Stock
- Owner
- BALL KRISTINE M
- Date
- 2026-11-12
- Code
- S
- Action
- Sale
- Quantity
- 200
- Price
- 106.9850
- Following holdings
- 0
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-12
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 200
- transaction Price Per Share: 106.9850
- id: F7
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
Stock Option (Right to Buy) (derivative)
- Owner
- BALL KRISTINE M
- Date
- 2026-11-12
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 18000
- Price
- 0
- Following holdings
- 53,426
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 6.84
- transaction Date: 2026-11-12
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 18000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F8
- expiration Date: 2034-05-06
- underlying Security Title: Common Stock
- underlying Security Shares: 18000
- shares Owned Following Transaction: 53426
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- BALL KRISTINE M: Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2026.
- F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.62 to $102.61, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6) and (7) to this Form 4.
- F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.66 to $103.65, inclusive.
- F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.69 to $104.65, inclusive.
- F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.76 to $105.75, inclusive.
- F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.76 to $106.46, inclusive.
- F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.97 to $107.00, inclusive.
- F8: The option vests as to 1/4 of the underlying shares on May 7, 2025 and as to 1/48 of the underlying shares monthly from May 7, 2025.
Original sources
Prepared automatically from public filing data. Report a correction.